96 phenotypes from 10 alleles in 18 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Isl1tm1(cre)Sev/Isl1+ Juntm4Wag/Jun+ Not Specified	interrupted aortic arch, type b	J:199412
Junem1(IMPC)Mbp/Jun+ C57BL/6N-Junem1(IMPC)Mbp/MbpMmucd	abnormal blood vessel morphology	J:211773
	abnormal craniofacial morphology	J:211773
	abnormal eye morphology	J:211773
	abnormal lymph node morphology	J:211773
	abnormal placenta morphology	J:211773
	anophthalmia	J:211773
	edema	J:211773
	enlarged lymph nodes	J:211773
	hyperactivity	J:211773
	increased prepulse inhibition	J:211773
Junem1(IMPC)Mbp/Junem1(IMPC)Mbp C57BL/6N-Junem1(IMPC)Mbp/MbpMmucd	abnormal blood vessel morphology	J:211773
	abnormal neural tube morphology	J:211773
	abnormal placenta morphology	J:211773
	edema	J:211773
	embryonic growth retardation	J:211773
	hemorrhage	J:211773
	preweaning lethality, complete penetrance	J:211773
Juntm1Bdc/Juntm1Bdc Not Specified	decreased neuron apoptosis	J:78265
Juntm1Pa/Juntm1Pa either: (involves: 129S/SvEv * 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J)	decreased fibroblast proliferation	J:13175
	embryonic lethality during organogenesis, complete penetrance	J:13175
Juntm1Pa/Juntm4Wag Isl1tm1(cre)Sev/Isl1+ involves: 129P2/OlaHsd * 129S/Sv * 129X1/SvJ * C57BL/6J	normal cardiovascular system phenotype	J:199412
	normal embryo phenotype	J:199412
Juntm1Pa/Juntm4Wag Tg(Tek-cre)1Ywa/0 involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL	normal embryo phenotype	J:199412
Juntm1Rsjo/Juntm1Rsjo Tg(KRT14-cre)8Brn/0 involves: 129S1/Sv * 129X1/SvJ * FVB/N	abnormal eyelid development	J:84743
	abnormal keratinocyte morphology	J:84743
	abnormal keratinocyte physiology	J:84743
	decreased keratinocyte proliferation	J:84743
	delayed wound healing	J:84743
	eye opacity	J:84743
	eyelids open at birth	J:84743
	failure of eyelid fusion	J:84743
	impaired wound healing	J:84743
	increased incidence of corneal inflammation	J:84743
	microphthalmia	J:84743
Juntm1Wag/Juntm1Wag either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6)	abnormal bile duct development	J:14538
	abnormal forebrain morphology	J:14538
	abnormal liver development	J:14538
	blood vessel congestion	J:14538
	dissociated hepatocytes	J:14538
	edema	J:14538
	embryonic lethality during organogenesis, incomplete penetrance	J:14538
	hepatic necrosis	J:14538
	increased hepatocyte apoptosis	J:14538
	increased nucleated erythrocyte cell number	J:14538
	lethality throughout fetal growth and development, complete penetrance	J:14538
Juntm1Wag/Juntm1Wag involves: 129S2/SvPas	decreased cell proliferation	J:175212
	oxidative stress	J:175212
Juntm1Wag/Juntm1Wag involves: 129S2/SvPas * C57BL/6	abnormal cardiac neural crest cell migration	J:55508
	decreased heart right ventricle wall thickness	J:55508
	decreased hepatocyte proliferation	J:55508
	increased hepatocyte apoptosis	J:55508
	persistent truncus arteriosus	J:55508
	right aortic arch	J:55508
	ventricular septal defect	J:55508
Juntm1Wag/Juntm5.1(Junb)Wag involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6	lethality throughout fetal growth and development, complete penetrance	J:75359
Juntm2.1Wag/Juntm2.1Wag involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA	decreased body size	J:53481
	decreased body weight	J:53481
	decreased cell proliferation	J:53481
	decreased cellular sensitivity to ultraviolet irradiation	J:53481
	decreased susceptibility to neuronal excitotoxicity	J:53481
	decreased susceptibility to pharmacologically induced seizures	J:53481
Juntm3.1Wag/Juntm3.1Wag involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA	no abnormal phenotype detected	J:53481
Juntm4Wag/Juntm4Wag Isl1tm1(cre)Sev/Isl1+ involves: 129P2/OlaHsd * 129S/Sv	abnormal aortic valve morphology	J:199412
	abnormal cardiac outflow tract development	J:199412
	abnormal pharyngeal arch artery morphology	J:199412
	abnormal pulmonary valve cusp morphology	J:199412
	abnormal pulmonary valve morphology	J:199412
	double outlet right ventricle	J:199412
	interrupted aortic arch, type b	J:199412
	normal mortality/aging	J:199412
	retroesophageal right subclavian artery	J:199412
	semilunar valve hyperplasia	J:199412
	ventricular septal defect	J:199412
Juntm4Wag/Juntm4Wag Tg(Alb1-cre)7Gsc/0 involves: 129P2/OlaHsd * FVB/N	abnormal liver regeneration	J:75863
	decreased body size	J:75863
	decreased liver weight	J:75863
Juntm4Wag/Juntm4Wag Tg(COL2A1-cre)1Wag/0 involves: 129P2/OlaHsd * C57BL/6 * CBA	abnormal thoracic cage morphology	J:80022
	scoliosis	J:80022
Juntm4Wag/Juntm4Wag Tg(Mx1-cre)1Cgn/0 involves: 129P2/OlaHsd * C57BL/6 * CBA	abnormal liver regeneration	J:75863
Juntm4Wag/Juntm4Wag Tg(Nes-cre)1Kln/0 involves: 129P2/OlaHsd * C57BL/6 * SJL	decreased neuron apoptosis	J:176956
	normal nervous system phenotype	J:176956
Juntm4Wag/Juntm4Wag Tg(Nes-cre)1Wme/0 involves: 129P2/OlaHsd * C57BL/6 * CBA	decreased body length	J:80022
	decreased body size	J:80022
	eyelids open at birth	J:80022
	fusion of vertebral arches	J:80022
	kyphosis	J:80022
	postnatal lethality, incomplete penetrance	J:80022
	prenatal lethality, incomplete penetrance	J:80022
	scoliosis	J:80022
Juntm4Wag/Juntm4Wag Tg(Sftpc-cre)1Blh/0 involves: 129P2/OlaHsd * C57BL/6 * DBA/2	abnormal cytokine level	J:179883
	abnormal pulmonary alveolar parenchyma morphology	J:179883
	abnormal pulmonary alveolar system morphology	J:179883
	abnormal tumor necrosis factor level	J:179883
	emphysema	J:179883
	increased lung apoptosis	J:179883
	lung inflammation	J:179883
Juntm4Wag/Juntm4Wag Tg(Tek-cre)1Ywa/0 involves: 129P2/OlaHsd * C57BL/6 * SJL	normal cardiovascular system phenotype	J:199412
	double outlet right ventricle	J:199412
	mitral valve hyperplasia	J:199412
	normal mortality/aging	J:199412
	perimembraneous ventricular septal defect	J:199412
	pulmonary valve hyperplasia	J:199412
	thick mitral valve cusps	J:199412
	thick pulmonary valve cusps	J:199412
	thin right ventricle myocardium compact layer	J:199412
Juntm5.1(Junb)Wag/Juntm5.1(Junb)Wag involves: 129P2/OlaHsd * C57BL/6	abnormal cell proliferation	J:75359
	abnormal truncus arteriosus septation	J:75359
	cyanosis	J:75359
	eyelids open at birth	J:75359
	failure of eyelid fusion	J:75359
	normal liver/biliary system phenotype	J:75359
	neonatal lethality, incomplete penetrance	J:75359
	perinatal lethality, incomplete penetrance	J:75359
	persistent truncus arteriosus	J:75359
	postnatal lethality, complete penetrance	J:75359
	ventricular septal defect	J:75359
Juntm6.1(Jund)Wag/Juntm6.1(Jund)Wag involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal neural tube morphology	J:175212
	decreased cell proliferation	J:175212
	embryonic growth retardation	J:175212
	embryonic lethality during organogenesis, incomplete penetrance	J:175212
	exencephaly	J:175212
	eyelids open at birth	J:175212
	normal liver/biliary system phenotype	J:175212
	neonatal lethality, complete penetrance	J:175212
	oxidative stress	J:175212
	persistent truncus arteriosus	J:175212